ATE412764T1 - Genetische transduktion von hämatopoietische vorläuferzellen - Google Patents
Genetische transduktion von hämatopoietische vorläuferzellenInfo
- Publication number
- ATE412764T1 ATE412764T1 AT99925991T AT99925991T ATE412764T1 AT E412764 T1 ATE412764 T1 AT E412764T1 AT 99925991 T AT99925991 T AT 99925991T AT 99925991 T AT99925991 T AT 99925991T AT E412764 T1 ATE412764 T1 AT E412764T1
- Authority
- AT
- Austria
- Prior art keywords
- hematopoietic
- cells
- genetic transduction
- progenic
- progenic cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2303—Interleukin-3 (IL-3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1394—Bone marrow stromal cells; whole marrow
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/06—Uses of viruses as vector in vitro
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8728498P | 1998-05-29 | 1998-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE412764T1 true ATE412764T1 (de) | 2008-11-15 |
Family
ID=22204258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99925991T ATE412764T1 (de) | 1998-05-29 | 1999-05-28 | Genetische transduktion von hämatopoietische vorläuferzellen |
Country Status (8)
Country | Link |
---|---|
US (1) | US8318495B1 (de) |
EP (2) | EP2019145A1 (de) |
AT (1) | ATE412764T1 (de) |
AU (1) | AU4216599A (de) |
CA (1) | CA2338344A1 (de) |
DE (1) | DE69939825D1 (de) |
ES (1) | ES2316187T3 (de) |
WO (1) | WO1999061644A1 (de) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5197985A (en) | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
ES2198403T3 (es) * | 1991-06-18 | 2004-02-01 | Osiris Therapeutics, Inc. | Celulas madre mesenquimaticas humanas derivadas de medula y anticuerpos monoclonales especificos para dichas celulas. |
AU680406B2 (en) * | 1992-03-04 | 1997-07-31 | Systemix, Inc. | Culturing of hematopoietic stem cells and their genetic engineering |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
WO1996009400A1 (en) * | 1994-09-19 | 1996-03-28 | Systemix, Inc. | Methods for genetically modifying hematopoietic stem cells |
EP0941027A4 (de) * | 1996-11-15 | 2000-08-09 | Osiris Therapeutics Inc | MSC-Megakaryozytenvorläuferzusammensetzung und Verfahren zum Isolieren von mit isolierten Megakaryozyten assoziierten MSCS durch die Isolierung von Megakaryozyten |
AU4094099A (en) * | 1998-05-22 | 1999-12-13 | Osiris Therapeutics, Inc. | Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
US7056738B2 (en) * | 2001-03-23 | 2006-06-06 | Tulane University | Early stage multipotential stem cells in colonies of bone marrow stromal cells |
US7592174B2 (en) * | 2002-05-31 | 2009-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Isolation of mesenchymal stem cells |
-
1999
- 1999-05-28 ES ES99925991T patent/ES2316187T3/es not_active Expired - Lifetime
- 1999-05-28 US US09/321,655 patent/US8318495B1/en not_active Expired - Fee Related
- 1999-05-28 EP EP08018067A patent/EP2019145A1/de not_active Withdrawn
- 1999-05-28 AT AT99925991T patent/ATE412764T1/de not_active IP Right Cessation
- 1999-05-28 AU AU42165/99A patent/AU4216599A/en not_active Abandoned
- 1999-05-28 CA CA002338344A patent/CA2338344A1/en not_active Abandoned
- 1999-05-28 DE DE69939825T patent/DE69939825D1/de not_active Expired - Lifetime
- 1999-05-28 WO PCT/US1999/011874 patent/WO1999061644A1/en active Application Filing
- 1999-05-28 EP EP99925991A patent/EP1084263B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69939825D1 (de) | 2008-12-11 |
US8318495B1 (en) | 2012-11-27 |
CA2338344A1 (en) | 1999-12-02 |
EP2019145A1 (de) | 2009-01-28 |
EP1084263A1 (de) | 2001-03-21 |
ES2316187T3 (es) | 2009-04-01 |
WO1999061644A1 (en) | 1999-12-02 |
AU4216599A (en) | 1999-12-13 |
EP1084263B1 (de) | 2008-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE295416T1 (de) | Humanisiertes grünes-fluoreszenzprotein und methoden | |
PT1062321E (pt) | Utilizacoes para celulas estaminais mesenquimais humanas nao autologas | |
DE60144145D1 (de) | Subtilisin-variante | |
DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
DK1084230T3 (da) | Regulering af hæmatopoietisk stamcelledifferentiering ved anvendelse af humane mesenkymstamceller | |
NO20025402D0 (no) | Modifiserte ES-celler og ES-spesifikt gen | |
BR9908018A (pt) | Adenovìrus modificado contendo uma proteìna de substituição de fibra | |
ATE317011T1 (de) | Expressionsvektoren und anwendungsmethoden | |
DE60017141D1 (de) | Replikationskompetente anti-tumor vektoren | |
PT1025245E (pt) | Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes | |
PT1007559E (pt) | Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso | |
PT1212428E (pt) | Redireccionamento da expressao do gene gama 34.5 de herpes atraves de um promotor especifico de celulas e/ou especifico de tumores | |
ATE342366T1 (de) | Rekombinantes konstrukt für eine erhöhte expression von genen in pflanzen. | |
DK1147134T3 (da) | Hidtil ukendte kaliumkanaler og gener, der koder for disse kaliumkanaler | |
ATE246935T1 (de) | Zns neuroregenerative zusammensetzungen und deren verwendungen | |
ATE412764T1 (de) | Genetische transduktion von hämatopoietische vorläuferzellen | |
DK0781344T3 (da) | Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme | |
FR2716205B1 (fr) | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. | |
ATE226638T1 (de) | Retroviraler vektor und dessen verwendung in gentherapie | |
DK1144666T3 (da) | Replikationsdeficient baculovirusekspressionssystem | |
AR013853A1 (es) | Un metodo para aumentar la expresion transgenica en una poblacion de celulas de monocotiledoneas y poblacion de celulas de monocotiledoneas conexpresion transgenica aumentada. | |
FR2603302A1 (fr) | Nouvelles souches de bacillus brevis et leur application | |
ATE292174T1 (de) | Gentransfer in humane lymphocyten mittels retroviraler scfv-zelltargeting vektoren | |
DE69535024D1 (de) | Verpackungszellinie zur transkomplementierung von defektiven retroviren-vektoren | |
ATE239074T1 (de) | Transduktion von menschlichen hämatopoiestischen stammzellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |